Ben Tre Pharmaceutical JSC (STC:DBT) EPS without NRI: ₫ (TTM As of . 20)


STC:DBT Ben Tre Pharmaceutical JSC STC:DBT
13 GF Score
Price ₫12,700.00
! 1 Warning Sign
View Full Analysis

What is Ben Tre Pharmaceutical JSC EPS without NRI?

Ben Tre Pharmaceutical JSC STC:DBT 13 EPS without NRI is ₫ as of . 20. GuruFocus rates STC:DBT with a GF Score™ of 13/100. The stock has 1 warning sign investors should review. Among 787 Drug Manufacturers companies, Ben Tre Pharmaceutical JSC ranks worse than 127064.68% on this metric.

Ben Tre Pharmaceutical JSC's earnings per share without non-recurring items for the six months ended in . 20 was ₫0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Ben Tre Pharmaceutical JSC's EPS without NRI or its related term are showing as below:

STC:DBT's 3-Year EPS without NRI Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.7
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Ben Tre Pharmaceutical JSC's EPS (Diluted) for the six months ended in . 20 was ₫0.00.

Ben Tre Pharmaceutical JSC's EPS (Basic) for the six months ended in . 20 was ₫0.00.


Ben Tre Pharmaceutical JSC  (STC:DBT) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Ben Tre Pharmaceutical JSC EPS without NRI Related Terms


Ben Tre Pharmaceutical JSC EPS without NRI Historical Data

* Premium members only.

The historical data trend for Ben Tre Pharmaceutical JSC's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ben Tre Pharmaceutical JSC EPS without NRI Chart

Ben Tre Pharmaceutical JSC Annual Data
Trend
EPS without NRI

Ben Tre Pharmaceutical JSC Semi-Annual Data
EPS without NRI

STC:DBT vs ZTS, UTHR, VTRS: EPS without NRI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ben Tre Pharmaceutical JSC's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ben Tre Pharmaceutical JSC PE Ratio without NRI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ben Tre Pharmaceutical JSC's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Ben Tre Pharmaceutical JSC's PE Ratio without NRI falls into.


STC:DBT
13GF Score
Ben Tre Pharmaceutical JSC STC:DBT
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ben Tre Pharmaceutical JSC EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS without NRI for the trailing twelve months (TTM) ended in . 20 was ₫

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of ₫ mean?
Ben Tre Pharmaceutical JSC (STC:DBT) has a EPS without NRI of ₫ as of . 20. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Ben Tre Pharmaceutical JSC and its competitors. According to the industry distribution chart, Ben Tre Pharmaceutical JSC ranks #999999 out of 787 companies in the Drug Manufacturers industry.
Is Ben Tre Pharmaceutical JSC's EPS without NRI too high?
Ben Tre Pharmaceutical JSC's current EPS without NRI is ₫. Based on the distribution chart, Ben Tre Pharmaceutical JSC ranks #999999 out of 787 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ben Tre Pharmaceutical JSC has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Ben Tre Pharmaceutical JSC's EPS without NRI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ben Tre Pharmaceutical JSC ranks #999999 out of 787 companies for EPS without NRI. This places Ben Tre Pharmaceutical JSC in the lower half of its industry. The industry median EPS without NRI is 9.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Drug Manufacturers company?
The median EPS without NRI among Drug Manufacturers companies is 9.70, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Ben Tre Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median EPS without NRI is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ben Tre Pharmaceutical JSC's current EPS without NRI is ₫. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ben Tre Pharmaceutical JSC stock overvalued right now?
Ben Tre Pharmaceutical JSC (STC:DBT) has a current EPS without NRI of ₫. The current EPS without NRI is ₫. Ben Tre Pharmaceutical JSC's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Ben Tre Pharmaceutical JSC (STC:DBT), the current EPS without NRI is ₫ as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ben Tre Pharmaceutical JSC Business Description

Address No. 6A3, National Highway 60, Phu Tan Ward, Vinh Long Province, Ben Tre, VNM
Ben Tre Pharmaceutical JSC is based in Vietnam. The company is engaged in trading in pharmaceuticals, functional foods, vaccines, cosmetics, medical equipment, & medical machinery. It is also engaged in the Import and export of testing chemicals & biological products, Manufacturing medicines for human treatment, producing pharmaceuticals, chemicals, and medicinal herbs, and Leasing warehouses and premises.
13GF Score

Get the complete analysis for STC:DBT

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫12,700.00
Price